Literature DB >> 11775463

Current diagnosis and treatment modalities for ovarian cancer.

Peter E Schwartz1.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11775463     DOI： 10.1007/978-1-4757-3587-1_4

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  34 in total

1.  Multimodality animal rotation imaging system (Mars) for in vivo detection of intraperitoneal tumors.

Authors:  John Pizzonia; Jennie Holmberg; Sean Orton; Ayesha Alvero; Oscar Viteri; William McLaughlin; Gil Feke; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2011-09-28       Impact factor: 3.886

2.  Enhancing the therapeutic effect against ovarian cancer through a combination of viral oncolysis and antigen-specific immunotherapy.

Authors:  Yu-Qian Zhang; Ya-Chea Tsai; Archana Monie; T-C Wu; Chien-Fu Hung
Journal:  Mol Ther       Date:  2010-01-19       Impact factor: 11.454

3.  TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214.

Authors:  G Yin; R Chen; A B Alvero; H-H Fu; J Holmberg; C Glackin; T Rutherford; G Mor
Journal:  Oncogene       Date:  2010-04-19       Impact factor: 9.867

4.  Delivery of chemotherapeutic agents using drug-loaded irradiated tumor cells to treat murine ovarian tumors.

Authors:  Daejin Kim; Talia Hoory; Archana Monie; Annie Wu; Wei-Ting Hsueh; Sara I Pai; Chien-Fu Hung
Journal:  J Biomed Sci       Date:  2010-07-26       Impact factor: 8.410

5.  Recent insights into the role of NF-kappaB in ovarian carcinogenesis.

Authors:  Ayesha B Alvero
Journal:  Genome Med       Date:  2010-08-25       Impact factor: 11.117

6.  Elevation of sulfatides in ovarian cancer: an integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry.

Authors:  Ying Liu; Yanfeng Chen; Amin Momin; Rebecca Shaner; Elaine Wang; Nathan J Bowen; Lilya V Matyunina; L Deette Walker; John F McDonald; M Cameron Sullards; Alfred H Merrill
Journal:  Mol Cancer       Date:  2010-07-12       Impact factor: 27.401

Review 7.  Development and validation of a protein-based signature for the detection of ovarian cancer.

Authors:  Kyongjin Kim; Irene Visintin; Ayesha B Alvero; Gil Mor
Journal:  Clin Lab Med       Date:  2009-03       Impact factor: 1.935

8.  Overexpression of ASAP1 is associated with poor prognosis in epithelial ovarian cancer.

Authors:  Teng Hou; Chenlu Yang; Chongjie Tong; Huiting Zhang; Juan Xiao; Jundong Li
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

9.  Enrichment of ovarian cancer stem-like cells is associated with epithelial to mesenchymal transition through an miRNA-activated AKT pathway.

Authors:  X Luo; Z Dong; Y Chen; L Yang; D Lai
Journal:  Cell Prolif       Date:  2013-08       Impact factor: 6.831

10.  KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells.

Authors:  Ki Hyung Kim; Yanhua Xie; Ewan M Tytler; Richard Woessner; Gil Mor; Ayesha B Alvero
Journal:  J Transl Med       Date:  2009-07-20       Impact factor: 5.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.